IL-17 Is a Key Regulator of Mucin-Galectin-3 Interactions in Asthma
Open Access
- 9 June 2021
- journal article
- research article
- Published by Wiley in International Journal of Cell Biology
- Vol. 2021, 1-11
Abstract
Mucus hypersecretion and chronic airway inflammation are standard characteristics of several airway diseases, such as chronic obstructive pulmonary disease and asthma. Increased mucus secretion from increased mucin gene expression in the airway epithelium is associated with poor prognosis and mortality. We previously showed that the absence of tissue inhibitor of metalloproteinase 1 (TIMP-1) enhances lung inflammation, airway hyperreactivity, and lung remodeling in asthma in an ovalbumin (OVA) asthma model of TIMP-1 knockout (TIMPKO) mice as compared to wild-type (WT) controls and mediated by increased galectin-3 (Gal-3) levels. Additionally, we have shown that in the lung epithelial cell line A549, Gal-3 inhibition increases interleukin-17 (IL-17) levels, leading to increased mucin expression in the airway epithelium. Therefore, in the current study, we further examined the relationship between Gal-3 and the production of IL-17-axis cytokines and critical members of the mucin family in the murine TIMPKO asthma model and the lung epithelium cell line A549. While Gal-3 may regulate a Th1/Th2 response, IL-17 could stimulate the mucin genes, MUC5B and MUC5AC. Gal-3 and IL-17 interactions induce mucus expression in OVA-sensitized mice. We conclude that Gal-3 may play an essential role in the pathogenesis of asthma, and modulation of Gal-3 may prove helpful in the treatment of this disease.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001412)
- National Institutes of Health (UL1TR001412)
- State University of New York (UL1TR001412)
This publication has 37 references indexed in Scilit:
- Mucins and their receptors in chronic lung diseaseClinical & Translational Immunology, 2020
- Mucins: the frontline defence of the lungBiochemical Society Transactions, 2018
- Role of Galectin‐3 in the pathophysiology underlying allergic lung inflammation in a tissue inhibitor of metalloproteinases 1 knockout model of murine asthmaImmunology, 2017
- TH17-associated cytokines (IL-17A and IL-17F) in severe asthmaJournal of Allergy and Clinical Immunology, 2009
- Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthmaClinical Immunology, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Critical Role for Galectin-3 in Airway Inflammation and Bronchial Hyperresponsiveness in a Murine Model of AsthmaThe American Journal of Pathology, 2004
- Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine LoopJournal of Biological Chemistry, 2003
- Goblet Cell and Mucin Gene Abnormalities in Asthma*Chest, 2002
- Supplement American Thoracic Society/ European Respiratory Society Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1999